ATLASCastle Biosciences (CSTL) earnings date: Nov 5, 2026
Castle Biosciences (CSTL) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.38.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CSTL
| Last price | $34.75 (-6.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Castle Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Castle Biosciences reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Castle Biosciences. You can switch it off at any time.
Alert me before CSTL reportsFree to start. Creating an account takes under a minute.
Notify me when Castle Biosciences reports
Track CSTL free Add Castle Biosciences to a free ATLAS watchlist and see its next report date in one place.
CSTL earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.38 |
| Last report | Jul 30, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +20.9% |
| Average move around a report | ±9.7% (last 5) |
| Sector | Healthcare · Diagnostics & Research |
Castle Biosciences earnings history: last 5 reports
Castle Biosciences last reported on Jul 30, 2026: EPS of -$0.07 against an estimate of -$0.41 (+82.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | -$0.41 | -$0.07 | +82.9% | Beat | +14.5% |
| May 19, 2026 | $0.24 | $0.34 | +41.7% | Beat | +3.7% |
| May 6, 2026 | -$0.49 | -$0.49 | 0.0% | In line | -21.8% |
| Apr 17, 2026 | $0.22 | $0.15 | -31.8% | Miss | +2.4% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +6.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CSTL
See the fair value, the probability range and the earnings history of Castle Biosciences on its ATLAS page.
Castle Biosciences (CSTL) stock analysisPlans from €3.99 a month.
Castle Biosciences earnings: frequently asked questions
When does Castle Biosciences (CSTL) report earnings?
Castle Biosciences is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CSTL?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.38 per share (USD). Estimates can change before the report.
How often does CSTL beat earnings estimates?
Of its last 5 reports with a recorded result, Castle Biosciences beat the EPS estimate 3 times; the average surprise was +20.9%. Past results do not predict the next one.
How much does CSTL move around earnings?
Over its last 5 reports the stock moved an average of 9.7% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Castle Biosciences beat earnings estimates last quarter?
Castle Biosciences last reported on Jul 30, 2026: EPS of -$0.07 against an estimate of -$0.41 (+82.9% surprise), a beat.
How much does CSTL usually move in a day?
On a normal trading day the ATLAS model puts CSTL’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer